文献速递神经肿瘤

术前血液炎症标志物作为胶质瘤患者预后因素

Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma.
PubMed 文献 · World Neurosurg · 2018-08-06

该回顾性病历回顾纳入2012年1月至2017年1月219例胶质瘤患者,评估中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、单核细胞与淋巴细胞比值(MLR)及红细胞分布宽度(RDW)的预后价值。高NLR与更高肿瘤分级相关(P=0.000),高NLR、PLR、MLR组中位总生存期(OS)均低于对应低值组,RDW高低组中位OS无显著差异;多因素分析显示NLR是OS的独立预测因素(HR 1.758,P=0.008)。

要点

  • 高NLR与更高肿瘤分级相关(P=0.000)。
  • 高NLR组中位OS 11个月 vs 低NLR组32个月(P=0.000)。
  • NLR是胶质瘤患者OS的独立预测因素(HR 1.758,P=0.008)。

核心结论

  • 术前高NLR、PLR和MLR可预测胶质瘤患者预后不良。
  • NLR是胶质瘤患者OS的独立预后因素。

研究设计与样本

  • 回顾性病历回顾,纳入2012年1月至2017年1月219例胶质瘤患者,评估NLR、PLR、MLR和RDW对预后的影响并分析这些血液炎症标志物间的相关性。

主要发现

  • 以受试者工作特征曲线截断值将患者分为高、低两组,高NLR与更高肿瘤分级相关(P=0.000)。
  • Kaplan-Meier生存分析显示,高NLR组中位OS 11个月 vs 低NLR组32个月(P=0.000);高PLR组中位OS 12个月 vs 低PLR组21个月(P=0.001);高MLR组中位OS 12个月 vs 低MLR组22个月(P=0.006)。
  • 高RDW组与低RDW组中位OS分别为15个月 vs 23个月,无显著差异(P=0.184)。
  • 多因素分析表明NLR是OS的独立预测因素(风险比1.758;P=0.008)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hematologic inflammatory markers are simple, inexpensive prognostic markers for various conditions. The prognostic significance of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and red blood cell distribution width (RDW) has been shown in a variety of tumors. We evaluated the prognostic value of these markers in glioma. METHODS: We performed a retrospective medical record review of 219 patients with glioma from January 2012 to January 2017, evaluating the effect of NLR, PLR, MLR, and RDW on prognosis. Correlations among these hematologic inflammatory markers were also examined. RESULTS: The patients were divided into high and low groups using the cutoff points from the receiver operating characteristic curves. High NLR was associated with a higher tumor grade (P = 0.000). Kaplan-Meier survival analyses showed that the high NLR, PLR, and MLR groups experienced inferior median overall survival (OS) compared with the low NLR, PLR, and MLR groups (11 vs. 32 months; P = 0.000; 12 vs. 21 months; P = 0.001; and 12 vs. 22 months; P = 0.006, respectively). No significant difference was found in the median OS between the high and low RDW groups (15 vs. 23 months; P = 0.184). Multivariate analysis demonstrated that NLR was an independent predictor of OS (hazard ratio, 1.758; P = 0.008). CONCLUSIONS: A high preoperative NLR, PLR, and MLR was predictive of a poor prognosis for patients with glioma. NLR was an independent prognostic factor for OS in patients with glioma.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bao Y, Yang M, Jin C, et al. Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma. World Neurosurg. 2018. PMID: 30092479. doi:10.1016/j.wneu.2018.07.252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。